SCM
Stonepine Capital Management Portfolio holdings
AUM
$114M
1-Year Est. Return
77.6%
This Fund
S&P 500
1 Year Est. Return
+77.6%
AUM
$114M
AUM Growth
-$12.7M
(-10%)
Holding
86
Top Buys
| 1 | +$13M | |
| 2 | +$5.51M | |
| 3 | +$3.52M | |
| 4 |
Curis
CRIS
|
+$3.41M |
| 5 |
Sol-Gel Technologies
SLGL
|
+$2.01M |
Top Sells
| 1 | +$3.59M | |
| 2 | +$2.47M | |
| 3 | +$2.39M | |
| 4 |
Eledon Pharmaceuticals
ELDN
|
+$2.02M |
| 5 |
Edesa Biotech
EDSA
|
+$1.97M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Verastem
VSTM
$345M
| $17.5M | 15.39% |
3,302,300
+570,221
|
|
||
2
Tenax Therapeutics
TENX
$297M
| $15.6M | 13.72% |
975,200
+963,316
|
|
||
3
Evolus
EOLS
$412M
| $7.23M | 6.36% |
1,759,091
+127,503
|
|
||
4
ADMA Biologics
ADMA
$1.76B
| $6.67M | 5.86% |
740,000
|
|
||
5
CAMP4 Therapeutics
CAMP
$207M
| $6.13M | 5.39% |
1,389,622
+1,160,728
|
|
||
6
Nektar Therapeutics
NKTR
$1.97B
| $6.12M | 5.38% |
85,000
|
|
||
7
Zevra Therapeutics
ZVRA
$657M
| $4.47M | 3.93% |
480,000
-89,088
|
|
||
8
Corbus Pharmaceuticals
CRBP
$133M
| $3.6M | 3.17% |
383,462
-6,454
|
|
||
9
Abeona Therapeutics
ABEO
$320M
| $3.34M | 2.94% |
746,587
+37,082
|
|
||
|
KZIA
10
Kazia Therapeutics
KZIA
$145M
| $2.57M | 2.26% |
345,179
-115,180
|
|
||
11
AN2 Therapeutics
ANTX
$150M
| $2.44M | 2.15% |
713,845
+86,177
|
|
||
|
12
Sol-Gel Technologies
SLGL
$236M
| $2.2M | 1.94% |
+27,778
|
|
||
13
Xoma
XOMA
$522M
| $2.18M | 1.92% |
69,500
-45,500
|
|
||
14
AYTU BioPharma
AYTU
$22.4M
| $2.16M | 1.9% |
792,289
-21,415
|
|
||
|
15
Curis
CRIS
$20.4M
| $2.04M | 1.79% |
3,726,406
+3,667,057
|
|
||
16
TELA Bio
TELA
$42.5M
| $1.62M | 1.43% |
2,617,252
+265,220
|
|
||
17
Inhibikase Therapeutics
IKT
$227M
| $1.61M | 1.41% |
957,202
-1,390,945
|
|
||
|
CBIO
18
Crescent Biopharma
CBIO
$496M
| $1.56M | 1.37% |
85,000
-2,682
|
|
||
19
Adicet Bio
ACET
$76.7M
| $1.51M | 1.33% |
221,955
+1,944
|
|
||
20
X4 Pharmaceuticals
XFOR
$388M
| $1.38M | 1.22% |
335,309
-258,264
|
|
||
|
OKYO
21
OKYO Pharma
OKYO
$89.2M
| $1.37M | 1.2% |
+850,000
|
|
||
22
Heron Therapeutics
HRTX
$98.4M
| $1.12M | 0.99% |
1,402,191
+164,389
|
|
||
23
Pulmonx
LUNG
$68M
| $991K | 0.87% |
768,288
+281,888
|
|
||
24
IN8bio
INAB
$15.9M
| $982K | 0.86% |
663,412
+498,519
|
|
||
25
Surrozen
SRZN
$269M
| $961K | 0.85% |
33,005
-80,626
|
|